HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,209,000 | +63.1% | 104,738 | +47.0% | 0.00% | +100.0% |
| Q3 2016 | $2,581,000 | +32.9% | 71,238 | +6.4% | 0.00% | 0.0% |
| Q2 2016 | $1,942,000 | -10.7% | 66,974 | +7.8% | 0.00% | 0.0% |
| Q1 2016 | $2,174,000 | +17.8% | 62,145 | +8.6% | 0.00% | 0.0% |
| Q4 2015 | $1,845,000 | +1.3% | 57,225 | +1.5% | 0.00% | 0.0% |
| Q3 2015 | $1,822,000 | -21.4% | 56,370 | +0.6% | 0.00% | 0.0% |
| Q2 2015 | $2,317,000 | -8.3% | 56,027 | -0.4% | 0.00% | 0.0% |
| Q1 2015 | $2,527,000 | +11.1% | 56,274 | -7.4% | 0.00% | 0.0% |
| Q4 2014 | $2,275,000 | +30.5% | 60,777 | +21.8% | 0.00% | 0.0% |
| Q3 2014 | $1,743,000 | -12.5% | 49,905 | -11.6% | 0.00% | 0.0% |
| Q2 2014 | $1,991,000 | -13.3% | 56,443 | -19.8% | 0.00% | 0.0% |
| Q1 2014 | $2,296,000 | -23.4% | 70,414 | -1.0% | 0.00% | -50.0% |
| Q4 2013 | $2,996,000 | +16.0% | 71,116 | +9.8% | 0.00% | 0.0% |
| Q3 2013 | $2,583,000 | +14.7% | 64,780 | +18.9% | 0.00% | 0.0% |
| Q2 2013 | $2,252,000 | – | 54,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |